+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 40Years +
All Genders
Healthy Volunteers
ID07585370

Long-Term Study of Live Attenuated Herpes Zoster Vaccine Effectiveness in Adults 40 Years and Older

Led by Jiangsu Province Centers for Disease Control and Prevention · Updated on 2026-05-13

24740

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the long-term effectiveness of a live attenuated herpes zoster vaccine in adults aged 40 years or older. This multicenter retrospective cohort study focuses on participants from a previous Phase III Clinical Trial conducted in 2020-2021, comparing those who originally received the vaccine with those who received a placebo. The study aims to assess the occurrence of herpes zoster over a period of up to six years after vaccination, including the impact of catch-up vaccination given after the vaccines marketing authorization in China.

CONDITIONS

Brief Title

Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine

Research Team

P

Pengfei Jin

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here